Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 2 of 51 for:    tazarotene

A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02411955
Recruitment Status : Completed
First Posted : April 8, 2015
Last Update Posted : May 4, 2017
Information provided by (Responsible Party):
Taro Pharmaceuticals USA

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2015
Actual Study Completion Date : February 2015